Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.38 |
| ▸ | OTC | P00480 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 3/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.35 |
| ▸ | GSR | P00390 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arginine SCHEMBL8582228 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL8697426 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL1675364 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL28774540 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL3087368 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL1417757 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL29164461 | 1.00 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL2123729 | 0.97 | PRCP (0.36) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL28470370 | 0.97 | PRCP (0.38) | PRCPOTCNOS2NOS3NOS1 | |
| Arginine SCHEMBL6535144 | 0.96 | PRCP (0.37) | PRCPOTCNOS2NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3149485-B1 | METHOD FOR DIAGNOSING A DISEASE OR A RISK TO DEVELOP A DISEASE TRANSMITTED VIA THE ALTERNATIVE PATHWAY OF THE COMPLEMENT SYSTEM | UNIV TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2021-03-03 | — | — | EP | claimed |
| CN-110691972-A | Disposable system for hemostatic function analysis | 海默索尼克斯有限公司 | 2020-01-14 | — | — | CN | claimed |
| US-20170160291-A1 | METHOD FOR THE DIAGNOSIS OF OR RISK FOR A DISEASE MEDIATED VIA THE ALTERNATIVE PATHWAY OF THE COMPLEMENT SYSTEM | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2017-06-08 | — | — | US | claimed |
| WO-2004110470-A2 | USE OF COLLAGEN PEPTIDES TO INHIBIT INFECTION | THE UNIVERSITY OF BRISTOL (GB) | 2004-12-23 | — | — | WO | claimed |
| US-20230228734-A1 | METHOD FOR FIBRINOGEN MEASUREMENT | A&T CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| CN-115561306-A | Disposable system for hemostatic function analysis | 海默索尼克斯有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-110691972-B | Disposable system for hemostatic function analysis | 海默索尼克斯有限公司 | 2022-11-04 | — | — | CN | disclosed |
| US-20220120768-A1 | REAGENT FOR MEASURING FIBRINOGEN | A&T CORPORATION (JP) | 2022-04-21 | — | — | US | disclosed |
| WO-2020116556-A1 | REAGENT FOR MEASURING FIBRINOGEN | 株式会社エイアンドティー | 2020-06-11 | — | — | WO | disclosed |
| CN-110691972-A | Disposable system for hemostatic function analysis | 海默索尼克斯有限公司 | 2020-01-14 | — | — | CN | disclosed |
| US-10416173-B2 | Method for the diagnosis of or risk for a disease mediated via the alternative pathway of the complement system | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2019-09-17 | — | — | US | disclosed |
| US-20170160291-A1 | METHOD FOR THE DIAGNOSIS OF OR RISK FOR A DISEASE MEDIATED VIA THE ALTERNATIVE PATHWAY OF THE COMPLEMENT SYSTEM | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2017-06-08 | — | — | US | disclosed |
| US-20040077028-A1 | Assay for thrombocytopenia associated with administration of platelet GPIIb-IIIa receptor antagonists | MASSACHUSETTS, UNIVERSITY OF | 2004-04-22 | — | — | US | disclosed |
| WO-2004017900-A2 | ASSAY FOR THROMBOCYTOPENIA ASSOCIATED WITH ADMINISTRATION OF PLATELET GPIIB-IIIA RECEPTOR ANTAGONISTS | UNIVERSITY OF MASSACHUSETTS (US) | 2004-03-04 | — | — | WO | disclosed |
| US-20030109431-A1 | Pro-inflammatory fibrinopeptide | VETERANS AFFAIRS, U.S. DEPARTMENT OF | 2003-06-12 | — | — | US | disclosed |
| US-20030109431-A1 | Pro-inflammatory fibrinopeptide | VETERANS AFFAIRS, U.S. DEPARTMENT OF | 2003-06-12 | — | — | US | disclosed |
| US-20020160523-A1 | Method for monitoring resting and activated platelets in unfixed blood samples | PPD BIOMARKER SERVICES, LLC | 2002-10-31 | — | — | US | disclosed |
| WO-2002025280-A1 | METHOD FOR MONITORING RESTING AND ACTIVATED PLATELETS IN UNFIXED BLOOD SAMPLES | SURROMED, INC. (US) | 2002-03-28 | — | — | WO | disclosed |
| US-5508202-A | MIXING SAMPLE AND FIBRIN PRECIPITATION INHIBITOR, ADDING THROMBIN SOLUTION, DETERMINING FIBRIN COAGULATION TIME IN PRESENCE OF CALCIUM ION, CAMPARING COAGULATION TIME WITH NORMAL COAGULATION TIME | NIPPON SHOJI KAISHA, LTD. (JP) | 1996-04-16 | — | — | US | disclosed |
| EP-0632270-A1 | METHOD OF ASSAYING ACTIVITY OF BLOOD COAGULATION FACTOR XIII AND REAGENT KIT THEREFOR | NIPPON SHOJI KABUSHIKI KAISHA (JP) | 1995-01-04 | — | — | EP | disclosed |